个人简介
Sarah Marktel医生是IRCCS圣拉斐尔科学研究医院血液病和骨髓移植科医生,主要面向遗传性贫血患者提供服务,在Fabio Ciceri教授的指导下开展工作。
Marktel医生于1997年从米兰大学医学院毕业,2002年在帕维亚大学获得血液学专业学位。多年来,她一直在国外进行各种实习,包括在伦敦大学各大医院,还是英国伦敦皇家学院的会员医师。
Marktel医生协助血液科患者在血液科日间医院接受治疗,特别是患有白血病、骨髓瘤、脊髓发育不全和先天性贫血的患者。其中也包括在治疗期间接受自体和异基因骨髓移植的患者。
在研究方面,Marktel医生主要关注地中海贫血的基因治疗。
Marktel医生以作者或共同作者的身份在行业学术期刊上发表了70多篇文章。她经常参加意大利国内外的行业会议。
教育背景
米兰大学
1997年,医学文凭课程,
帕维亚大学,
2002年,血液学专业学位
出版物
最新出版物
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ßthalassemia.
Nat Med. 2019 Feb;25(2):234-241.
扩展阅读
Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs.
Am J Hematol. 2016 Jun;91(6):E302-3.
扩展阅读
Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000- 2010.
Bone Marrow Transplant. 2016 Apr;51(4):536-41.
扩展阅读
High rate of hematological responses to sorafenib in FLT3- ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.
Eur J Haematol. 2015
扩展阅读
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
Biol Blood Marrow Transplant 2015
扩展阅读
Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis.
Hematol Oncol. 2014
扩展阅读
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.
Leukemia. 2015
扩展阅读
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.
Leukemia. 2014 Jun 4
扩展阅读
Unpredictability of iv Busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplant for advanced beta thalassemia: Limited toxicity with a dose adjustment policy.
Biol Blood Marrow Transplant. 2009
扩展阅读
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
N Engl J Med. 2009 Jan 29;360(5):447-58.
扩展阅读